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Background: Hemodiafiltration (HDF), as a convective blood purification technique, has been associated with
favorable outcomes improved phosphate control, removal of middle-molecules such as Beta2-microglobulin and
the occurrence of intradialytic hypotension (IDH) as compared to diffusive techniques. The aim of this retrospective
cohort study in dialysis patients receiving HDF in one urban dialysis facility in Mexico City was to investigate the
occurrence of IDH during HDF treatments with varying convective volume prescriptions.
Methods: Subjects were stratified into equal groups of percentiles of convective volume prescription: Group 1 of 0
to 7.53 liters, group 2 of 7.54 to 14.8 liters, group 3 of 14.9 to 16.96 liters, group 4 of 16.97 to 18.9 liters, group 5 of
21 to 19.9 liters and group 6 of 21.1 to 30 liters. Logistic Regression with and without adjustment for confounding
factors was used to evaluate factors associated with the occurrence of IDH.
Results: 2276 treatments of 154 patients were analyzed. IDH occurred during 239 HDF treatments (10.5% of all
treatments). Group 1 showed 31 treatments (8.2%) with IDH whereas group 6 showed IDH in only 15 sessions (4%
of all treatments). Odds Ratio of IDH for Group 6 was 0.47 (95% CI 0.25 to 0.88) as compared to Group 1 after
adjustment.
Conclusions: In summary the data of this retrospective cohort study shows an inverse correlation between the
occurrence of IDH and convective volume prescription. Further research in prospective settings is needed to
confirm these findings.
Keywords: Intradialytic hypotension, Hemodiafiltration, Convective volumeBackground
Despite continuous progress of dialysis technologies
intradialytic hypotension (IDH) remains a major prob-
lem in the treatment of patients suffering from chronic
kidney disease stage 5D [1-3].
Rapid removal of intravascular volume by ultrafiltra-
tion results in hemodynamic instability if it exceeds the
compensatory vascular refilling from the interstitial vol-
ume [4,5]. The critical blood volume at which symptom-
atic hypotension occurs varies from patient to patient
[4,6,7] and is influenced by myocardial contractility, heart* Correspondence: franklin.mora.bravo@gmail.com
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distribution, and reproduction in any mediumrate, and peripheral vascular resistances [8]. It may also
be noted that the vascular response to reduction in blood
volume is additionally strongly determined by changes in
body temperature during the treatment. Factors such as
the mass transfer of sodium and calcium have also been
reported to associate to hemodynamic stability.
Regular use of high-efficiency on line HDF is associated
with reduced morbidity (better blood pressure control,
improved lipid profile, improved anemia correction and
phosphate control, improved removal of beta2-microglo-
bulin, reduction of amyloidosis and hospitalization) [9-11].
A reduction of inflammatory markers during has also
been reported recently [12]. More recently, several cohort
studies have shown that high-efficiency on line HDF is
associated with a reduced risk of mortality [9,13]. It hastral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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purification may improve patient outcomes, which may
include a reduction of intradialytic hypotensive episodes
[14-17].
Hemodiafiltration can be categorized according to the
used convective volume replacement during the course
of the treatment. Low-efficiency HDF includes replace-
ments of 5 to 14.9 liters, whereas high-efficiency HDF
includes replacement of 15 to 24.9 liters. A recently pub-
lished analysis of the Dialysis Outcomes and Practice Pat-
terns Study (DOPPS) reported an association between
survival and the amount of convective volume [13].
To the best of the authors’ knowledge the relation of
the convective volume during HDF and intradialytic
hypotension has not been studied to date. This retro-
spective cohort study aimed to evaluate the relation be-
tween the occurrence of intradialytic hypotension and




The database contains records of 167 patients and 6137
treatments. We selected cases for analysis from that
group.
Subjects received thrice-weekly HDF sessions for a
minimum duration of 3 hours during the period from
07/01/2005 and 07/16/2006 in the dialysis unit of the
Instituto Nacional De Cardiología Ignacio Chavez in
Mexico City, were included in this analysis. Patients
were stratified into 6 equal groups of convection volume
prescription (based on percentiles of convective volume
in the entire dataset), and for a confirmatory analysis
into 7 groups, where the reference group was not receiv-
ing HDF with convective volume. This retrospective
study was approved by the Institutional Review Board of
Instituto Nacional de Cardiología Ignacio Chávez (Refer-
ence #: IMIN-2010-TL-27).
Treatment characteristics
Extracorporeal blood Flow (Qb) was chosen according
to the unit's policy and was aimed keep the arterial pres-
sure between −200 to −250 mmHg, but with a prescrip-
tion limit of 500 ml/min. Patients received systemic
anticoagulation with heparin-sodium 2.000 units at the
beginning of treatment and 1000 units per hour. In
addition dialysis filters and -lines were also heparinized
with 1000 units of sodium-heparin in a 1 liter of 0.9%
saline solution.
Postdilutional HDF sessions were delivered by Frese-
nius 4008 H dialysis machines (Fresenius Medical Care
Germany, Bad Homburg, Germany). The machines are
equipped with a pre pump measuring system for dy-
namic arterial line pressure, blood temperature monitor(BTM) for measurements of access recirculation, an on-
line clearance monitor (OCM) and the blood Volume
Monitor (BVM). Urea Kinetic Volume in Litters was
determined by Watson Formula [18].
High-Flux polysulfone membrane dialyzers F-60 and
F-80 were used (Fresenius Medical Care North America,
Walnut Creek, CA, USA). Dialysis filters and blood lines
were re-used up to 10 ± 4 times and disinfected by for-
maldehyde after each treatment. Dialysate/infusate com-
positions were sodium 135 mEq/L, potassium 3 mEq/L,
calcium 3 mEq/L, bicarbonate 30 mEq/L and glucose
200 mg/dL. Ultra pure bicarbonate dialysate was deliv-
ered. The studied patients had no dietary fluid or salt
restrictions, but were recommended high protein and
calorie intake. Prescription of sufficient convective vol-
ume was made aiming for a trans-membranous pressure
of 200 mmHg.
IDH was defined as per the K/DOQI guidelines [19],
defined as a decrease in systolic BP of 20 mmHg or a de-
crease in mean arterial pressure (MAP) by 10 mmHg
associated with clinical events, such as headache, nausea,
vomiting and cramps, and the need for nursing interven-
tions as per standard of care (injection of a 50 mL bolus
of hyperosmolar glucose, placing the patient in Trende-
lenburg position and temporary cease of ultrafiltration).
UF rate algorithm
The relative blood volume (RBV) was measured on line
with the Blood Volume Monitor (BVM). At the start of
hemodialysis the RBV was equal to 100%. We program
the critical limit for stopping ultrafiltration, when RBV is
less than 78%. We program the ultrafiltration maximum
rate with a value of 3000 mL/hour.
Statistical analysis
Data was tested for normal distribution by Shapiro-Wilk
test. Parametric data was reported as mean standard de-
viation and non-parametric as median [Inter quartile
Range (IQR) from 25th to 75th percentile]. Differences
between groups were tested by means of Analysis of
Variance (ANOVA) and Post-Hoc Bonferroni-Dunnett
Test. Logistic Regression analysis with only groups of
convective volume included was employed to test the
hypothesis that convective volume associates to the oc-
currence of IDH. Additional adjustment of the model by
relevant clinical parameters [pre HDF systolic blood
pressure (SBP), albumin, ultrafiltration rate, pre HDF
body temperature, post HDF weight] was employed to
exclude confounding of the results.
Results
Study cohort
Records of 2276 post-dilution HDF session of 154
patients were included in this retrospective cohort study.
Mora-Bravo et al. BMC Nephrology 2012, 13:106 Page 3 of 8
http://www.biomedcentral.com/1471-2369/13/106Patients were categorized in six equal groups according
to percentiles of convective volume prescription data:
Group 1: 0 to 7.53 liters, Group 2: 7.54 to 14.8 liters;
Group 3: 14.9 to16.96 liters; Group 4: 116.97 to 18.9
liters; Group 5: 19.1 to 21 liters, and Group 6: 21.1 to 30
liters. All patients were of Hispanic ethnicity, the rest of
the demographics of the studied cohort are shown in
Table 1. None of the subjects had an active prescription
of antihypertensive medication.
Treatment characteristics
HD parameters are shown in Table 2. Treatment time,
conductivity, dialysate temperature, arterial and venous
line pressure, sodium prescription was similar in all
studied groups (Table 2). Small significant differences
between the groups were found for processed blood vol-
ume, total spent dialysate, blood and dialysate flow
(Table 3). The achieved ionic Kt/V in the studied treat-
ments showed significant differences between the
groups, with higher values associating to higher convec-
tion volumes. Information on interdialytic weight gain
expressed as percentage of dry weight is in the Table 1.
Intradialytic hypotension
During the study period, IDH occurred in 239 study
treatments (10.5% of all studied HD sessions; Table 4).
Logistic regression was employed to analyze the associ-
ation of convective volume to the occurrence of intradia-
lytic symptoms. The first model included only groups ofTable 1 Patients demographics
Parameter Sixtiles of convective vo
Group 1 Group 2 Group 3 G
Patients [count] 23 25 22
Treatments [count] 379 382 377
Age [Years] 43.4 ± 15 44.5 ± 16 48.2 ± 11 4
Gender Female [count [%]] 11 [47.8%] 12 [48%] 10 [45.5%] 1
Pre HDF Weight [Kg] 63.8 ±13.0 61.6 ±12.5 61.4 ±13.0 6
Post HDF Weight [Kg] 61.4 ± 13.0 58.5 ± 12.2 58.7 ± 13.1 5
Temperature pre HDF [Celsius] 36.72 ± 0.36 36.55 ± 0.45 36.56 ± 0.42 36
Temperature post HDF [Celsius] 36.98 ± 0.39 36.81 ± 0.50 36.84 ± 0.48 36
Delta Temperature [Celsius] 0.27 ± 0.29 0.27 ± 0.38 0.28 ± 0.37 0
Interdialytic Weight Gain
[% post HDF target weight]
4.2 ± 2.0 5.2 ± 2.1 4.8 ± 2.5
Pre HDF Systolic Blood
Pressure [mmHg]
136 ± 29 147± 28 143 ± 28 1
Pre HDF Diastolic Blood
Pressure [mmHg]
70 ± 20 77 ± 21 75 ± 22
Pre HDF MAP Blood
Pressure [mmHg]
93 ± 23 102± 23 99 ± 23
Pre HDF Pulse Rate [bpm] 94 ± 15 93 ± 16 94 ± 18
Group 1: 0 to 7.53 liters, Group 2: 7.54 to 14.8 liters; Group 3: 14.9 to 16.96 liters; Gr
liters. Not significant (NS).convective volume (Table 5a) and showed a significantly
decreased risk of IDH as compared to the reference
group. After inclusion of relevant clinical parameters this
relation remained significant (Table 5b). For the con-
firmatory analysis all subjects were stratified in 7 groups
of convective volume, where the reference group did re-
ceive HDF with convective volume. The results were
similar to the primary analysis and showed that Group 7
had a lower risk of IDH as compared to group 1 and 2
(Table 6 and Figure 1). Ultrafiltration rate register each
15 minutes is in the Table 7.
Discussion
Statement of principal findings
The present study shows that the group with the highest
convective volume used for HDF has the lowest occur-
rence of IDH. This association was independent of rele-
vant clinical factors such as pre HDF SBP, albumin,
ultrafiltration rate, pre HDF body temperature and post
HDF weight. A confirmatory analysis where patients re-
ceiving treatment with no convective volume were used
as the reference group showed results consistent with
the primary analysis. A non-significant trend of increas-
ing risk of IDH with decreasing convective volume may
be interpreted in Table 5a and b.
Strengths
It may be outlined that potential confounders such as di-
alysate temperature, dialysate sodium and calcium didlume prescription Anova Dunnett Post Hoc Test
roup 4 Group 5 Group 6 P<0.05 P>0.05
29 27 28
382 380 376
3.2 ± 16 46.3 ± 14 48.9 ± 12 NS None 1 vs. 2-6
4 [48%] 12 [44%] 11 [39%] NS Chi Square Test
1.0 ±12.8 60.5 ±12.7 60.8 ±15.3 NS None 1 vs. 2-6
8.2 ± 12.8 57.9 ± 12.6 59.4 ± 13.0 NS None 1 vs. 2-6
.54 ± 0.41 36.55 ± 0.43 36.55 ± 0.42 NS None 1 vs. 2-6
.85 ± 0.39 36.85 ± 0.39 36.82 ± 0.38 NS None 1 vs. 2-6
.30 ± 0.29 0.28 ± 0.27 0.28 ± 0.28 NS None 1 vs. 2-6
5.0 ± 2.3 4.6 ± 2.2 4.0 ± 2.1 <0.0001 1 vs. 2-4 1 vs. 5-6
39 ± 27 137± 26 136 ± 26 <0.0001 1 vs. 2-3 1 vs. 4-6
75 ± 23 71 ± 22 69 ± 21 <0.0001 1 vs. 2-4 1 vs. 5,6
98 ± 23 95 ± 22 93 ± 22 <0.0001 1 vs. 2-4 1 vs5,6
95 ± 15 94 ± 16 94 ± 16 NS None 1 vs.2-6
oup 4: 16.97 to 18.9 liters; Group 5: 19.1 to 21 liters, and Group 6: 21.1 to 30
Table 2 Characteristics of hemodiafiltration (HDF) treatments
Parameter Group 1 Group 2 Group 3 Group 4 Group 5 Group 6 Anova P<0.05 P>0.05
Effective Dialysis Time [min] 217 ± 14 205 ± 17 210± 18 214 ± 17 217 ± 17 219 ± 16 NS None 1 vs. 2-6
Total Blood Volume [liters]* 88.6 ± 14.5 74.8 ± 15.8 82.5 ± 13.4 88.7 ± 12.6 92.2 ± 11.4 97.2 ± 10.5 <0.0001 1 vs.5,6. 1 vs.2-4
Extracorporeal Blood Flow [mL/min] 406 ± 63 361 ± 71 389± 62 412 ± 58 423 ± 55 442 ± 52 <0.0001 1 vs.5,6. 1 vs.2-4
Dialysate Flow [ml/min] 522 ± 41 613 ± 36 632± 37 643 ± 45 672 ± 47 703 ± 34 <0.0001 1 vs.2-6 None
Ultrafiltration [litters] 2.62 ± 0.85 3.05 ± 1.03 2.89 ± 1.12 2.97 ± 1.14 2.67 ± 1.09 2.41 ± 1.04 <0.0001 1 vs.2-4 1 vs.5,6
Conductivity [mS/cm3] 14.0 ± 0.2 14.0 ± 0.1 14.1 ± 0.1 14.1 ± 0.1 14.1 ± 0.1 14.1 ± 0.1 NS None 1 vs.2-6
Dialysate temperature [Celsius] 35.74 ± 0.35 35.64 ± 0.37 35.64 ± 0.38 35.62 ± 0.35 35.64 ± 0.30 35.68 ± 0.32 NS None 1 vs.2-6
Arterial Line Pressure [mmHg] −201 ± 35 −205 ± 34 −211± 29 −218 ± 26 −217 ± 27 −215 ± 28 NS None 1 vs.2-6
Venous Line Pressure [mmHg] 205 ± 53 176 ± 59 176± 46 180 ± 41 186 ± 40 198 ± 44 NS None 1 vs.2-6
Dialysate sodium prescription [mEq/L] 138 ± 0.7 138 ± 0.8 138± 0.6 138 ± 0.6 138 ± 0.6 138 ± 0.4 NS None 1 vs.2-6
* Total Blood Volume =Qb*Dialysis Time. Group 1: 0 to 7.53 liters, Group 2: 7.54 to 14.8 liters; Group 3: 14.9 to 16.96 liters; Group 4: 16.97 to 18.9 liters; Group 5:
19.1 to 21 liters, and Group 6: 21.1 to 30 liters. Not significant (NS).
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be considered a strength of the present analysis. It is also
important to note that potential confounders of the ana-
lysis such as ultrafiltration rate and albumin, which are
main determinants of vascular refilling in response to
interdialytic fluid removal, were included in an adjusted
Logistic Regression model and did not alter the results.
Particularly the inclusion of ultrafiltration rate in the
analysis reduces the possible confounding influence
caused by the significant differences found in interdialy-
tic weight gain (Table 1). Inclusion of pre HDF SBP
excludes the possibility that patients with higher SBP
may have larger decreases (and thus higher likelihood of
experiencing IDH) or those with lower SBP may have
lower cardiac function and thus more likely to experi-
ence IDH. An additional strength of this analysis is theTable 3 Clinical parameters
Parameter Group 1 Group 2 Group 3 Grou
Recirculation
fraction [%]
13.0 ± 6.7 14.4 ± 9.0 12.1 ± 6.6 12.5 ±
Ionic Kt/V 1.37 ± 0.33 1.27 ± 0.34 1.39 ± 0.36 1.44 ±
Urea Kinetic
Volume [Liters]
31.3 ± 5.5 31.0 ± 6.8 33.2 ± 7.3 33.0 ±
Clearance [ml/min] 183 ± 36 172 ± 50 196± 36 209 ±
Minimum RBV [%] 82.5 ± 7.3 80.1 ± 7.2 80.3 ± 8.6 80.3 ±
Haemoglobin
post HDF [g/dL]
9.4 ± 2.7 10.1 ± 2.6 9.8 ± 2.8 9.7 ± 2
Haemoglobin
pre HDF [g/dL]
7.2 ± 1.8 7.5 ± 1.9 7.2 ± 1.8 7.2 ± 2
pre HDF BWC [%] 86.4 ± 1.4 86.1 ± 1.6 86.4 ± 1.6 86.4 ±
post HDF BWC [%] 84.5 ± 2.3 83.9 ± 2.3 84.2 ± 2.4 84.3 ±
Δ Haemoglobin
[g/dL]
2.2 ± 1.3 2.7 ± 1.4 2.6 ± 1.5 2.5 ± 1
Δ BWC [g/dL] 1.9 ± 1.1 2.2 ± 1.2 2.2 ± 1.3 2.1 ± 1
Hemodiafiltration (HDF). Blood Water Component (BWC). Δ Hemoglobin = pre-post
liters; Group 3: 14.9 to 16.96 liters; Group 4: 16.97 to 18.9 liters; Group 5: 19.1 to 21sample size which is considerable large with 2276 HDF
treatments in 154 included subjects.
Weaknesses of the study
Limitations of the current study are the retrospective na-
ture of the analysis it is based on a re analysis of avail-
able data, and the considerably homogenous study
population recruited in an urban dialysis facility in Mex-
ico City. This trial has no information about water trans-
fer from the vascular into the interstitial space, effective
circulating volume, accurate information on mass trans-
fer of solutes possibly relevant for hemodynamic stability
(in particular sodium or calcium) and measurement of
inflammatory markers serum interleukins. Additional
confounding may have occurred due to differences in
change of body core temperature which may alter thep 4 Group 5 Group 6 Anova P<0.05 P>0.05
8.7 13.8 ± 8.5 13.1 ± 7.4 NS None 1 vs.2-6
0.41 1.60 ± 0.39 1.66 ± 0.38 <0.0001 1 vs.5,6 1 vs.2-4
7.0 31.7 ± 7.3 33.7 ± 7.9 NS None 1 vs.2-6
32 219 ± 31 235± 31 <0.0001 1 vs.3-6 1 vs.2
8.3 82.4 ± 8.5 85.2 ± 7.4 <0.001 2 vs.6 1 vs .2-6
.9 9.0 ± 2.7 8.4 ± 2.4 <0.0001 1 vs.2 1 vs.3-6
.0 6.8 ± 1.8 6.7 ± 1.8 <0.0001 2 vs.6 1 vs.2-6
1.8 86.7 ± 1.7 86.8 ± 1.6 NS None 1 vs.2-6
2.5 85.0 ± 2.1 85.4 ± 2.1 <0.0001 1 vs.5-6 1 vs.2-4
.4 2.2 ± 1.3 1.8 ± 1.0 <0.0001 1 vs.2-4 1 vs.5,6
.2 1.8 ± 1.1 1.4 ± 0.9 <0.0001 1 vs.2-4 1 vs.5,6.
HDF, Δ BWC=pre – post HDF. Group 1: 0 to 7.53 liters, Group 2: 7.54 to 14.8
liters, and Group 6: 21.1 to 30 liters.
Table 4 Occurrence of intradialytic hypotension (IDH) during hemodiafiltration (HDF) treatments stratified into sixtiles
according to the convective volume used
Sixtiles of convective volume prescription Total
Group 1 Group 2 Group 3 Group 4 Group 5 Group 6
Treatments [count] 379 382 377 382 380 376 2276
no IDH [Count [%]] 348 [91.8%] 314 [82.2%] 324 [85.9%] 343 [89.8%] 347 [91.3%] 361 [96.0%] 2037 [89.5%]
IDH [Count [%]] 31 [8.2%] 68 [17.8%] 53 [14.1%] 39 [10.2%] 33 [8.7%] 15 [4.0%] 239 [10.5%]
Group 1: 0 to 7.53 liters, Group 2: 7.54 to 14.8 liters; Group 3: 14.9 to 16.96 liters; Group 4: 16.97 to 18.9 liters; Group 5: 19.1 to 21 liters, and Group 6: 21.1 to 30
liters.
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No measurements of body core temperature were per-
formed. Peripheral pre and post temperature was mea-
sured by blood thermal monitor and did not show
significant differences (Table 1).
Strengths and weaknesses in relation to other studies
Very few of the studies comparing HD and HDF have
taken into account that these techniques differ in the op-
erative settings of several variables potentially affecting theTable 5 Logistic regression analysis to determine odds ratio o
(IDH)
a] B S.E. Wald
Groups 43.31
Sixtil (1) 0.888 0.230 14.88
Sixtil (2) 0.608 0.239 6.47
Sixtil (3) 0.244 0.252 0.94
Sixtil (4) 0.065 0.261 0.06
Sixtil (5) −0.763 0.323 5.56
Constant −2.418 0.187 166.45
b] B S.E. Wald
Groups 28.172
Sixtil (1) 0.726 0.247 8.598
Sixtil (2) 0.525 0.250 4.405
Sixtil (3) 0.140 0.263 0.285
Sixtil (4) −0.058 0.277 0.044
Sixtil (5) −0.679 0.330 4.247
Pre Systolic Blood Press 0.007 0.004 3.778
Pre Diastolic Blood Press 0.003 0.004 0.375
Albumine −0.428 0.167 6.545
Ultrafiltration 0.0001 0.0001 12.316
Effective Dialysis Time 0.0001 0.004 0.005
Delta Temperature 0.023 0.107 0.048
Post Weight −0.009 0.006 2.197
Constant −2.214 1.300 2.903
Table 5a) shows the association between convective volume and the occurrence of
relevant parameters.
The groups of convective volume were defined as follows: Group 1: 0 to 7.53 liters,
liters; Group 5: 19.1 to 21 liters, and Group 6: 21.1 to 30 liters.hemodynamic response to the procedure, namely, the rate
of convective transport, the efficiency of small and large
solute removal, the buffer used in the dialysate, sodium
balance, treatment time and the type of membrane. A re-
cently reported study in 34 patients reported that replace-
ment volumes greater than 16 liters HDF not have a
protective effect of hypotension [20]. Is this trial Pinney,
et al. used a replacement volume from 16 to 21 liters. In
general the results are consistent with our results because
the 16-liter volume used in our work gives an OR of 1.059f hemodiafiltration volume for intradialytic hypotension
df Sig. Exp[B] 95,0% C.I. for EXP[B]
Lower Upper
5 <0.0001 1
1 <0.0001 2.43 1.55 3.82
1 0.011 1.84 1.15 2.93
1 0.334 1.28 0.78 0.78
1 0.802 1.07 0.64 1.78
1 0.018 0.47 0.25 0.88
1 <0.0001 0.09
df Sig. Exp(B) 95% C.I.for EXP(B)
Lower Upper
5 <0.0001
1 0.003 2.066 1.272 3.356
1 0.036 1.690 1.035 2.758
1 0.594 1.151 0.687 1.926
1 0.834 0.944 0.549 1.623
1 0.039 0.507 0.266 0.967
1 0.052 1.007 1.000 1.014
1 0.541 1.003 0.994 1.011
1 0.011 0.652 0.469 0.905
1 <0.0001 1.000 1.000 1.000
1 0.945 1.000 0.992 1.008
1 0.827 1.024 0.830 1.262
1 0.138 0.991 0.980 1.003
1 0.088 0.109
IDH without adjustment, and b) shows the Odds ratio after adjustment for
Group 2: 7.54 to 14.8 liters; Group 3: 14.9 to 16.96 liters; Group 4: 16.97 to 18.9
Table 6 Logistic regression analysis to determine Odds Ratio of hemodiafiltration volume for Intradialytic Hypotension
B S.E. Wald Sig. Exp[B] 95,0% C.I. for EXP[B]
Lower Upper
Nhdfvol 43.328 <0.0001
Nhdfvol (1) −0.115 0.760 0.023 0.879 0.891 0.201 3.952
Nhdfvol (2) 0.880 0.236 13.976 <0.0001 2.412 1.520 3.827
Nhdfvol (3) 0.600 0.244 6.045 0.014 1.822 1.129 2.939
Nhdfvol (4) 0.236 0.257 0.843 0.358 1.266 0.0765 2.096
Nhdfvol(5) 0.058 0.266 0.047 0.829 1.059 0.629 1.784
Nhdfvol (6) −0.770 0.327 5.547 0.019 0.463 0.244 0.879
Constant −2.410 0.194 154.604 <0.0001 0.090
The groups of convective volume were defined as follows: Group 1: 0 to 0.2 liters. Group 2: 0.3 to 7.53 liters, Group 3: 7.54 to 14.8 liters; Group 4: 14.9 to 16.96
liters; Group 5: 16.97 to 18.9 liters; Group 6: 19.1 to 21 liters, and Group 7: 21.1 to 30 liters.
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volumes greater than 21 liters are those which decrease
the risk of IDH. Several studies, carried out subsequently,
reinforced the belief that procedures based on convective
transport are superior to those based on diffusive trans-
port in protecting the stability of blood pressure and heart
rate [2-4,6,7].
Possible mechanisms
Strong support in favor of HDF came from a series of
hemodynamic studies showing that, for equal amounts of
fluid removed, HDF elicited an appropriate increase in
peripheral vascular resistance, whereas standard HD failed
to do so [8]. Shaldon et al. hypothesized that the dialysate
itself must be “the” vascular stabilizer with a rationale
interleukin removal as the framework of the hypothesis
[21]. Interleukins increase capillary permeability, resultingFigure 1 Forest plot diagram to represent odds ratio of hemodiafiltra
convective volume were defined as follows: Group 1: 0 to 0.2 liters. Group
liters; Group 5: 16.97 to 18.9 liters; Group 6: 19.1 to 21 liters, and Group 7: 2in water capillary leakage from the vascular into the inter-
stitial space. This hypothesis has not yet specifically been
investigated for HDF treatments, but recently a reduction
of inflammatory markers in patients receiving HDF treat-
ments has been reported [12]. To what extent this is
related and consistent with the hypothesis of Shaldon
et al. requires further research. An additional aspect which
also requires more research is the mass transfer of sodium
and calcium. Although a positive sodium transfer will raise
the osmolality and quite likely result in increased interdia-
lytic weight gains and blood pressure, a negative sequelae
which should be avoided in patients suffering from renal
impairment. However, it may not be excluded that mast
transfer of sodium confounded our results by changing
serum osmolality and affecting hemodynamic stability.
The same accounts for calcium mass transfer, which is
also of hemodynamic importance for patients receivingtion volume for Intradialytic Hypotension. The groups of
2: 0.3 to 7.53 liters, Group 3: 7.54 to 14.8 liters; Group 4: 14.9 to 16.96
1.1 to 30 liters.
Table 7 Ultrafiltration rate by time
Groups Dunett Test
1 2 3 4 5 6 Total Anova P< 0.05 P> 0.05
UF rate 15 min (mL/min) 20 ± 14 23 ± 17 22 ± 17 26 ± 24 23 ± 20 23 ± 22 23 ± 19 <0.001 1 vs. 4. 1 vs 2,3,5,6
UF rate 30 min (mL/min) 20 ± 8 23 ± 9 21± 9 22± 9 20± 8 17± 8 20± 9 <0.0001 1 vs 2–4. 1 vs 5,6.
UF rate 45 min (mL/min) 18 ± 8 21 ± 8 19± 8 20± 9 18± 7 16± 8 19± 8 <0.0001 1 vs 2,4. 1 vs 3,5,6.
UF rate 60 min (mL/min) 16 ± 6 18 ± 8 17± 8 18± 7 17± 9 15± 6 17± 7 <0.0001 1 vs 2–4. 1 vs 5,6.
UF rate 75 min (mL/min) 14 ± 6 17 ± 6 15± 6 16± 6 15± 6 13± 6 15± 6 <0.0001 1 vs 2–4. 1 vs 5,6.
UF rate 90 min (mL/min) 12 ± 5 15 ± 6 14± 6 14± 5 13± 5 12± 5 13± 5 <0.0001 1 vs 2–5. 1 vs 6.
UF rate 105 min (mL/min) 11 ± 6 13 ± 6 13± 5 12± 5 12± 5 11± 4 12± 5 <0.0001 1 vs 2–4. 1 vs 5,6.
UF rate 120 min (mL/min) 10 ± 6 13 ± 6 12± 5 11± 5 11± 5 10± 4 11± 5 <0.0001 1 vs 2–4. 1 vs 5,6.
UF rate 135 min (mL/min) 10 ± 5 12 ± 5 11± 5 11± 5 10± 4 9 ± 4 10± 5 <0.0001 1 vs 2–4. 1 vs 5,6.
UF rate 150 min (mL/min) 9 ± 6 11 ± 6 10± 5 10± 5 9 ± 4 8 ± 4 9 ± 5 <0.0001 1 vs 2–4. 1 vs 5,6.
UR rate 165 min (mL/min) 8 ± 5 10 ± 5 9 ± 5 9 ± 5 8 ± 4 7 ± 4 9 ± 5 <0.0001 1 vs 2–4. 1 vs 5,6.
UF rate 180 min (mL/min) 8 ± 9 11 ± 9 10± 9 10± 10 8 ± 7 7 ± 5 9 ± 8 <0.0001 1 vs 2–4. 1 vs 5,6.
UF rate 210 min (mL/min) 9 ± 22 15 ± 22 11 ± 14 10 ± 9 10± 25 7 ± 8 10± 16 <0.0001 1 vs 2. 1 vs 3–6.
The groups of convective volume were defined as follows: Group 1: 0 to 0.2 liters. Group 2: 0.3 to 7.53 liters, Group 3: 7.54 to 14.8 liters; Group 4: 14.9 to 16.96
liters; Group 5: 16.97 to 18.9 liters; Group 6: 19.1 to 21 liters, and Group 7: 21.1 to 30 liters.
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Sande et al. [22]. The techniques that are based on con-
vective transport also entail a significant cooling of the
blood flowing in the extracorporeal circuit [23-27] which
may also affect hemodynamic stability. This is because in
an isothermal treatment, difference between arterial line
temperature (from the patient) and the venous line
temperature (from the machine) is greater than 0.5
degrees Celsius for the arterial line (measured by Blood
Thermal Monitor).
Conclusions
At this point no definitive statement can be given and
additional research is needed to confirm the findings of
this research in a prospective setting. However, in sum-
mary the data of this retrospective cohort study shows
an inverse correlation between the occurrence of intra-
dialytic hypotension and convective volume prescription.
This study is limited by its retrospective design and, al-
though quite promising initial results in terms of
hemodynamic stability are shown, much additional re-
search is needed.
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